SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SP 15D2 - Special Financial Report [Rule 15d-2]:
SEC Accession No. 0001213900-24-045127
Filing Date
2024-05-20
Accepted
2024-05-20 15:32:42
Documents
60
Period of Report
2023-12-31
Effectiveness Date
2024-05-20

Document Format Files

Seq Description Document Type Size
1 SPECIAL FINANCIAL REPORT ea0206419-sp15d2_ostherap.htm   iXBRL SP 15D2 558323
2 CERTIFICATION ea020641901ex31-1_ostherap.htm EX-31.1 3997
3 CERTIFICATION ea020641901ex31-2_ostherap.htm EX-31.2 3982
4 CERTIFICATION ea020641901ex32-1_ostherap.htm EX-32.1 4765
5 CERTIFICATION ea020641901ex32-2_ostherap.htm EX-32.2 4784
  Complete submission text file 0001213900-24-045127.txt   4205746

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE osti-20231231.xsd EX-101.SCH 57107
7 XBRL CALCULATION FILE osti-20231231_cal.xml EX-101.CAL 25533
8 XBRL DEFINITION FILE osti-20231231_def.xml EX-101.DEF 226936
9 XBRL LABEL FILE osti-20231231_lab.xml EX-101.LAB 410467
10 XBRL PRESENTATION FILE osti-20231231_pre.xml EX-101.PRE 232932
64 EXTRACTED XBRL INSTANCE DOCUMENT ea0206419-sp15d2_ostherap_htm.xml XML 508931
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

IRS No.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SP 15D2 | Act: 34 | File No.: 333-271034 | Film No.: 24964116
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)